rs2276961

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020041.3(SLC2A9):​c.73G>A​(p.Gly25Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.525 in 1,613,966 control chromosomes in the GnomAD database, including 227,232 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 16328 hom., cov: 34)
Exomes 𝑓: 0.53 ( 210904 hom. )

Consequence

SLC2A9
NM_020041.3 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.194

Publications

50 publications found
Variant links:
Genes affected
SLC2A9 (HGNC:13446): (solute carrier family 2 member 9) This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
SLC2A9-AS1 (HGNC:40636): (SLC2A9 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.5187014E-5).
BP6
Variant 4-10021357-C-T is Benign according to our data. Variant chr4-10021357-C-T is described in ClinVar as Benign. ClinVar VariationId is 347006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.568 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC2A9NM_020041.3 linkc.73G>A p.Gly25Arg missense_variant Exon 1 of 12 ENST00000264784.8 NP_064425.2 Q9NRM0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC2A9ENST00000264784.8 linkc.73G>A p.Gly25Arg missense_variant Exon 1 of 12 1 NM_020041.3 ENSP00000264784.3 Q9NRM0-1

Frequencies

GnomAD3 genomes
AF:
0.440
AC:
66971
AN:
152052
Hom.:
16319
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.211
Gnomad AMI
AF:
0.713
Gnomad AMR
AF:
0.489
Gnomad ASJ
AF:
0.499
Gnomad EAS
AF:
0.426
Gnomad SAS
AF:
0.585
Gnomad FIN
AF:
0.525
Gnomad MID
AF:
0.455
Gnomad NFE
AF:
0.540
Gnomad OTH
AF:
0.457
GnomAD2 exomes
AF:
0.515
AC:
129356
AN:
251402
AF XY:
0.524
show subpopulations
Gnomad AFR exome
AF:
0.202
Gnomad AMR exome
AF:
0.537
Gnomad ASJ exome
AF:
0.517
Gnomad EAS exome
AF:
0.424
Gnomad FIN exome
AF:
0.531
Gnomad NFE exome
AF:
0.540
Gnomad OTH exome
AF:
0.518
GnomAD4 exome
AF:
0.534
AC:
780055
AN:
1461796
Hom.:
210904
Cov.:
60
AF XY:
0.536
AC XY:
389939
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.196
AC:
6576
AN:
33480
American (AMR)
AF:
0.530
AC:
23695
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.517
AC:
13516
AN:
26136
East Asian (EAS)
AF:
0.448
AC:
17793
AN:
39700
South Asian (SAS)
AF:
0.597
AC:
51454
AN:
86254
European-Finnish (FIN)
AF:
0.534
AC:
28535
AN:
53420
Middle Eastern (MID)
AF:
0.466
AC:
2674
AN:
5740
European-Non Finnish (NFE)
AF:
0.544
AC:
605128
AN:
1111954
Other (OTH)
AF:
0.508
AC:
30684
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
23239
46478
69718
92957
116196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17044
34088
51132
68176
85220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.440
AC:
66989
AN:
152170
Hom.:
16328
Cov.:
34
AF XY:
0.442
AC XY:
32910
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.210
AC:
8738
AN:
41520
American (AMR)
AF:
0.489
AC:
7481
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.499
AC:
1729
AN:
3468
East Asian (EAS)
AF:
0.426
AC:
2204
AN:
5174
South Asian (SAS)
AF:
0.586
AC:
2828
AN:
4830
European-Finnish (FIN)
AF:
0.525
AC:
5560
AN:
10590
Middle Eastern (MID)
AF:
0.449
AC:
131
AN:
292
European-Non Finnish (NFE)
AF:
0.540
AC:
36702
AN:
67980
Other (OTH)
AF:
0.457
AC:
966
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1883
3765
5648
7530
9413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.513
Hom.:
24604
Bravo
AF:
0.426
TwinsUK
AF:
0.546
AC:
2024
ALSPAC
AF:
0.551
AC:
2124
ESP6500AA
AF:
0.216
AC:
952
ESP6500EA
AF:
0.537
AC:
4618
ExAC
AF:
0.510
AC:
61941
Asia WGS
AF:
0.509
AC:
1767
AN:
3478
EpiCase
AF:
0.542
EpiControl
AF:
0.528

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30315176) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypouricemia, renal, 2 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
5.0
DANN
Benign
0.92
DEOGEN2
Benign
0.039
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.066
N
LIST_S2
Benign
0.38
T
MetaRNN
Benign
0.000015
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.19
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.020
N
REVEL
Benign
0.075
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.013
B
Vest4
0.056
MutPred
0.20
Loss of glycosylation at P29 (P = 0.0224);
MPC
0.13
ClinPred
0.015
T
GERP RS
-0.40
PromoterAI
-0.082
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.18
gMVP
0.25
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276961; hg19: chr4-10022981; COSMIC: COSV53316288; COSMIC: COSV53316288; API